Publications

Active matter, encompassing both natural and artificial systems, utilizes environmental energy to sustain autonomous motion, exhibiting unique non-equilibrium behaviors. Artificial active matter (AAM), such as nano/micromotors, holds transformative potential in precision medicine by enhancing drug delivery and enabling targeted therapeutic interventions. Under the demand for increasing intelligence in AAM, controlling their non-equilibrium processes within complex in vivo environments presents significant challenges. Endogenous fields-biological fields generated within living systems-play a pivotal role in guiding natural active matter's (NAM) directional migration and collective transformations, offering a strategy for in vivo control of non-equilibrium systems. Research in NAMs-inspired AAMs spans biology, chemistry, materials science, engineering, and physics, yet communication barriers among disciplines often impede progress. This review seeks to bridge these gaps by summarizing the key characteristics of chemical and physical endogenous fields in biological contexts such as tumors, wounds, and inflammation. It explores how natural and artificial active matter sense, transmit, and execute responses to these fields, and discusses how insights from natural systems can inform the design of synthetic counterparts. Potential issues and prospects of this research direction are also discussed. It is hoped that this review fosters interdisciplinary collaborations and propels the development of intelligent active matter for biomedical applications.

JTD Keywords: Acoustic propulsion, Active matter, Cell-migration, Collective behavior, Endogenous fields, Exhaled breath condensate, Extracellular ph, Hydrogen-peroxide, In-vivo, Interstitial fluid pressure, Nanomotors, Shear-wave elastography, Stimuli-responsive polymers, Tumor microenvironment

The puropse of this study was to evaluate associations of cisterna chyli (CCh) diameter with portal hemodynamics and the influence of TIPS-creation in cirrhotic patients. 93 cirrhotic patients (57 male, mean age 59 years) received CT prior to TIPS-creation. 38/93 additionally underwent post-interventional CT. CCh-diameter was measured. After categorization into patients with and without large venous collaterals (i.e. > 6 mm), data were analyzed regarding associations between CCh-diameter, clinical and portal-hemodynamic parameters and diameter-changes after TIPS-creation. Patient survival post-TIPS was analyzed. Median portosystemic pressure-gradient decreased from 20 to 9 mmHg after TIPS-creation. Large venous collaterals were observed in 59 patients. In 69/93 patients (74.2%) the CCh was detectable. Mean pre-interventional diameter was 9.4 ± 2.7 mm (large collaterals: 8.7 ± 2.0 mm, no large collaterals: 10.7 ± 3.2 mm, p = 0.003). CCh-diameter correlated strongly with pre-TIPS portal-pressure (Rs = 0.685, p = 0.0001), moderately with portosystemic-gradient (Rs = 0.524, p = 0.006), liver shear-wave-elastography (Rs = 0.597, p = 0.004) and spleen size (Rs = 0.501, p = 0.01) in patients without large collaterals, but not in patients with large collaterals. Post-TIPS CCh-diameter decreased significantly from 10.2 ± 2.8 mm to 8.3 ± 3.0 mm (p < 0.001). Patients without a detectable CCh on CT survived significantly shorter. The diameter of the CCh is associated with portal-pressure and decreases after TIPS-creation in cirrhotic patients, reflecting a portal decompression mechanism via the lymphatic system. Lack of larger central lymphatics detectable on CT may be associated with shorter survival.

JTD Keywords: circulation, cisterna chyli, fluid, hepatic cirrhosis, shear-wave elastography, thoracic-duct, vessels, Significant portal-hypertension